{
  "docId": "019de074-1317-767b-825b-77b5f795fc6c",
  "docSlug": "27adacda91e6c92061c4de59bd9e9dc9",
  "documentTitle": "Theravance Biopharma | Investor Conference Presentation Deck | 44 slides",
  "authorId": "theravance-biopharma",
  "authorName": "Theravance Biopharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 44,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 22,
  "notes": "The slide includes a table of adverse events and bulleted takeaways regarding clinical safety parameters.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-1317-767b-825b-77b5f795fc6c/28",
  "deckHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c",
  "deckJsonHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c.json",
  "deckAnchorHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.92,
        "x": 0.04,
        "y": 0.62
      },
      "kind": "list",
      "text": "TEAEs were similar between placebo and ampreloxetine groups; No adverse events of supine hypertension were observed; No clinically significant differences for laboratory parameters, ECG changes, ambulatory BP monitoring, and vital signs; Two deaths: 1 respiratory tract infection (unrelated) and 1 unknown cause",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb5cef7c-d610-4c31-96bc-b8990d4bc8f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.55
      },
      "kind": "source-note",
      "text": "All data are presented as n (%). Ampreloxetine was administered at 10 mg once daily. Death of unknown cause was imputed as related to treatment. BP, blood pressure; ECG, electrocardiogram; SAE, serious adverse event; TEAE, treatment-emergent adverse event.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53859d22-c391-4752-90df-e1fe380e10f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.84,
        "x": 0.08,
        "y": 0.188
      },
      "kind": "table",
      "text": "Placebo (n=64) vs Ampreloxetine (n=64) for TEAEs, SAEs, and deaths.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb7bb16e-4e7b-4cf5-bd3e-c206ed83ba48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.28,
        "x": 0.04,
        "y": 0.03
      },
      "kind": "title",
      "text": "Safety Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "17d1e6da-7dae-4585-99e6-1482d9dd93b9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.3,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Randomized Withdrawal Period",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0bdd962-ccdf-4d82-885a-984a31ed7724",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}